Folic Acid
Stroke, Ischemic
Jaime Daniel MondragonSmall moleculePhase 2/3Dormant
B
57/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 42/ 100
- Competitive Position
- 89/ 100
Competitive context
10 Active assets in the Stroke, Ischemic cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
mlc1501 Moleac Pte Ltd. | Phase 2/3 | BB |
D-thioctic acid Chonnam National University Hospital | Phase 3 | B |
Hydrogen Stony Brook University | Phase 2/3 | B |
Hydroxyurea Vanderbilt University Medical Center | Phase 2/3 | B |
NEBIVOLOL Aristotle University Of Thessaloniki | Phase 2 | B |
View all 25 →
Same molecule, other indications
Folic Acid is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →